Ketan K. Dhatariya MBBS, MSc, MD, Ms, FRCP, PhDConsultant in Diabetes, Endocrinology and General Medicine, Hon Professor of Medicine, University of East Anglia, Elsie Bertram Diabetes Centre, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, Norfolk, United Kingdom
Ketan Dhatariya qualified from the University of London in 1991 and did his diabetes and endocrinology training in and around London. For 2 years during his training he was also a part time General Practitioner in the evenings. He took some time out of his training to spend a year doing intensive care medicine and anaesthetics. After he finished his diabetes training in 2001 he went to do research in endocrinology at Mayo Clinic in Minnesota, USA. He was appointed as a consultant in diabetes, endocrinology and general medicine at the Norfolk & Norwich University Hospital in 2004, and Honorary Reader in Medicine at the University of East Anglia in 2017. He is a full time clinician and his predominant areas of interest are inpatient diabetes – in particular peri-operative diabetes care, the management of diabetes related emergencies, and the ‘diabetic foot’. He leads one of the largest foot clinics in the East of England.
He has several national roles in the UK. He is currently on the steering group of the Joint British Diabetes Societies Inpatient Care Group where he has led or co-authored several national guidelines on the management of various aspects of inpatient diabetes care including the guideline on peri-operative diabetes care. He is the Chair of the Examining Board for the UK Specialist Clinical Exam in Diabetes and Endocrinology, as well as Chair of the newly developed European Board Examination in Endocrinology, Diabetes and Metabolism. He is the President-Elect and Honorary Secretary of the Diabetes and Endocrine section of the Royal Society of Medicine. He is an Associate Editor of Diabetic Medicine.
Dr Dhatariya has over 100 peer reviewed publications, over 100 abstracts, and has published several book chapters on inpatient diabetes, peri-operative diabetes care or on the diabetic foot. He was awarded a PhD on inpatient diabetes in 2017 by the University of East Anglia.
Recent Contributions to PracticeUpdate:
- Lower Extremity Amputation Risk and Incidence in Type 1 Diabetes
- Glycemic Control and Diabetic Foot Ulcer Outcomes
- Outcomes in Patients With Type 2 Diabetes Mellitus and Peripheral Artery Disease: The EXSCEL Trial
- Resurgence of Diabetes-Related Nontraumatic Lower-Extremity Amputation in the Young and Middle-Aged US Adults
- SGLT2 Inhibitors Associated With Lower-Extremity Amputation Among Patients With Type 2 Diabetes
- DPP-4 Inhibitors Improve Diabetic Wound Healing via Direct and Indirect Promotion of Epithelial–Mesenchymal Transition and Reduction of Scarring
- Cardiovascular Outcomes and Safety of Empagliflozin in Patients With Type 2 Diabetes and PAD